These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12487391)

  • 41. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission.
    Rinonce HT; Yano Y; Utsumi T; Heriyanto DS; Anggorowati N; Widasari DI; Lusida MI; Soetjipto ; Prasanto H; Hotta H; Hayashi Y
    J Med Virol; 2013 Aug; 85(8):1348-61. PubMed ID: 23919229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular epidemiology of hepatitis C virus infection in dialysis patients.
    Fabrizi F; Lunghi G; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F
    Nephron; 1997; 77(2):190-6. PubMed ID: 9346386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus genotypes in chronic dialysis patients.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1996 Apr; 11(4):679-83. PubMed ID: 8671858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
    Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: clinical perspectives.
    Fabrizi F; Martin P; Lunghi G; Ponticelli C
    Int J Artif Organs; 2000 Dec; 23(12):805-16. PubMed ID: 11197739
    [No Abstract]   [Full Text] [Related]  

  • 46. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.
    Selcuk H; Kanbay M; Korkmaz M; Gur G; Akcay A; Arslan H; Ozdemir N; Yilmaz U; Boyacioglu S
    Dig Dis Sci; 2006 Aug; 51(8):1420-5. PubMed ID: 16868830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)].
    Tanaka M; Fujiyama S; Tanaka M; Itoh K; Matsushita K; Hara M; Kuwahara K; Yasumoto N; Nishimura Y; Yoshimura N; Tomita K
    Nihon Jinzo Gakkai Shi; 2003; 45(2):91-7. PubMed ID: 12703404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation?
    Harmankaya O; Cetin B; Obek A; Seber E
    Ren Fail; 2002 Sep; 24(5):639-44. PubMed ID: 12380910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus infections in dialysis units: prevalence of HCV-RNA and antibodies to HCV.
    Seelig R; Renz M; Bottner C; Seelig HP
    Ann Med; 1994 Feb; 26(1):45-52. PubMed ID: 8166987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil.
    Freitas SZ; da Cunha RV; Martins RM; Teles SA; Ibanhes ML; Motta-Castro AR
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):405-8. PubMed ID: 18660998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical significance of detection and quantification of hepatitis C virus RNA in hemodialysis: proposal for a rational diagnostic strategy].
    Halfon P; Pol S; Sayada C; Izopet J; Rostaing L; Ouzan D
    Nephrologie; 1997; 18(2):53-8. PubMed ID: 9182234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occult hepatitis C virus infection in hemodialysis patients: examining the evidence.
    Kamar N; Nicot F; Izopet J; Rostaing L
    Am J Kidney Dis; 2009 Jul; 54(1):10-2. PubMed ID: 19324484
    [No Abstract]   [Full Text] [Related]  

  • 54. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection with GB virus C and hepatitis C virus in drug addicts, patients on maintenance hemodialysis, or with chronic liver disease in Nepal.
    Shrestha SM; Shrestha S; Tsuda F; Sawada N; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1997 Oct; 53(2):157-61. PubMed ID: 9334927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatitis C virus infection in hemodialysis patients].
    Li JS
    Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):655-7, 701. PubMed ID: 1284485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study.
    Akpolat T; Arik N; Günaydin M; Utaş C; Dilek K; Caglar S; Candan F; Süleymanlar G; Paydaş S; Sen S
    Nephrol Dial Transplant; 1995; 10(4):479-80. PubMed ID: 7542753
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk of hepatitis C virus infection in hemodialysis patients.
    D'Aquino M; Michieletto L; Tempesta D; Pipan C
    Hepatology; 1994 Apr; 19(4):1061. PubMed ID: 7511128
    [No Abstract]   [Full Text] [Related]  

  • 60. IgM antibodies to hepatitis C virus and haemodialysis patients.
    Navarro JF; Teruel J; Mateos M; Ortuño J
    Nephrol Dial Transplant; 1994; 9(8):1211. PubMed ID: 7528362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.